OpenAlex
PricingAboutJobs
Log inGet started
Work

PI3K/Akt/mTOR signaling pathway in cancer stem cells

HTML

Year: 2022
Type: review
Source: Pathology - Research and Practice
DOI: 10.1016/j.prp.2022.154010
Authors: Mohsen Karami fath, Menooa Ebrahimi, Ehsan Nourbakhsh, Ahmad Zia Hazara, Ali Mirzaei, Saba Shafieyari, Azadeh Salehi, Mahsa Hoseinzadeh, Zahra Payandeh, Ghasem Barati
Institutions: Kharazmi University, Qazvin University of Medical Sciences, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Shahid Sadoughi University of Medical Sciences and Health Services, Shiraz University of Medical Sciences, Hamedan University of Medical Sciences, Islamic Azad University Central Tehran Branch, Islamic Azad University, Jahrom Branch, Karolinska Institutet, Stem Cell Technology Research Center
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: cancer stem cells, PI3K/AKT/mTOR pathway, drug resistance, tumor heterogeneity, stemness maintenance, epithelial-mesenchymal transition, autophagy, cell migration, targeted cancer therapy, PI3K inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4283792791
FWCI: 3.715
Cites: 113
Cited by: 189
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms